These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8522475)

  • 1. Marked variation in pyrimethamine disposition in AIDS patients treated for cerebral toxoplasmosis.
    Winstanley P; Khoo S; Szwandt S; Edwards G; Wilkins E; Tija J; Coker R; McKane W; Beeching N; Watkin S
    J Antimicrob Chemother; 1995 Aug; 36(2):435-9. PubMed ID: 8522475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of pyrimethamine in serum and penetration into brain tissue in humans.
    Leport C; Meulemans A; Robine D; Dameron G; Vildé JL
    AIDS; 1992 Sep; 6(9):1040-1. PubMed ID: 1388895
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.
    Derouin F; Gérard L; Farinotti R; Maslo C; Leport C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):50-4. PubMed ID: 9732069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Azithromycin combined with pyrimethamine in the treatment of neurotoxoplasmosis, in an AIDS patient].
    Trotta M; Sterrantino G; Milo D; Dionisio D; Leoncini F
    Minerva Med; 1997 Mar; 88(3):117-9. PubMed ID: 9148227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients.
    Laing RB; Flegg PJ; Brettle RP; Leen CL; Burns SM
    Int J STD AIDS; 1996 Jul; 7(4):258-64. PubMed ID: 8876356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
    Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
    Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral trimethoprim-sulfamethoxazole in the treatment of cerebral toxoplasmosis in AIDS patients--a prospective study.
    Francis P; Patel VB; Bill PL; Bhigjee AI
    S Afr Med J; 2004 Jan; 94(1):51-3. PubMed ID: 14971234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS.
    Weiss LM; Harris C; Berger M; Tanowitz HB; Wittner M
    J Infect Dis; 1988 Mar; 157(3):580-3. PubMed ID: 3343528
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cerebral symptomatic toxoplasmosis treated by sulfadoxine/pyrimethamine treatment. About 6 patients].
    Iba-Ba J; Ibouili RB; Kombila JB; Nzenze JR; Drave M; Essola L; Ivala M; Mistoul I; Kerault L; Menye B; Boguikouma JB
    Therapie; 2008; 63(1):71-2. PubMed ID: 18556837
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids.
    Arens J; Barnes K; Crowley N; Maartens G
    S Afr Med J; 2007 Oct; 97(10):956-8. PubMed ID: 18000578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
    Langmann P; Klinker H; Richter E
    Dtsch Med Wochenschr; 1995 May; 120(21):780-1. PubMed ID: 7781508
    [No Abstract]   [Full Text] [Related]  

  • 12. Clindamycin in the treatment of toxoplasmosis in AIDS.
    Iannucci AA; Hart LL
    Ann Pharmacother; 1992 May; 26(5):645-7. PubMed ID: 1591424
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients].
    Ferrer S; Fuentes I; Domingo P; Muñoz C; Iranzo A; Barrio JL; Fuster M; Ris J; Sambeat MA; Cadafalch J; Nolla J
    An Med Interna; 1996 Jan; 13(1):4-8. PubMed ID: 8679824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS.
    de Gans J; Portegies P; Reiss P; Troost D; van Gool T; Lange JM
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):137-42. PubMed ID: 1732505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant cerebral toxoplasmosis diagnosed by magnetic resonance imaging.
    Picardi M; De Rosa G; Di Salle F; Pezzullo L; Raiola A; Rotoli B
    Haematologica; 1998 Jun; 83(6):570-2. PubMed ID: 9676033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDS.
    Klinker H; Langmann P; Richter E
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1623-7. PubMed ID: 8807051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse of Toxoplasma encephalitis and susceptibility to pyrimethamine: lack of evidence of treatment-induced resistance.
    Caramello P; Brancale T; Forno B; Lucchini A; Pollono AM; Ullio A; Gioannini P; Viano I; Tonso E
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2371-2. PubMed ID: 8619602
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clindamycin in cerebral toxoplasmosis].
    Gato A; Gaspar G; Pontes J; Ballesteros P
    Enferm Infecc Microbiol Clin; 1991; 9(7):445-6. PubMed ID: 1799624
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
    J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program.
    Kovacs JA
    Lancet; 1992 Sep; 340(8820):637-8. PubMed ID: 1355212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.